Related Experiment Video
Updated: Sep 16, 2026

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice
Published on: February 3, 2012
Increased Liver-Related Morbidity in Autoimmune Hepatitis-Primary Sclerosing Cholangitis Variant Syndrome: A
Muhammad Hassaan Arif Maan1, Soban Maan2, Anand Shah1
1Department of Medicine, Rutgers New Jersey Medical School, Newark, New Jersey.
Background And Aims:
Autoimmune hepatitis-primary sclerosing cholangitis (AIH-PSC) variant syndrome is characterized by concurrent hepatitic and cholestatic liver injury, yet data on long-term outcomes relative to both component diseases remain limited.
Methods:
Using the TriNetX Research Network, we performed 2 separate 1:1 propensity score-matched (PSM) analyses comparing AIH-PSC to AIH alone and to PSC alone, matching on demographics, comorbidities, and baseline laboratory values. A 180-day landmark was applied. Primary outcomes included cirrhosis, hepatocellular carcinoma, liver transplantation, all-cause hospitalization, and long-term steroid use. Cholangiocarcinoma (CCA) was analyzed separately using multivariable Cox regression. Hazard ratios (HRs) served as the primary effect measure.
Results:
After matching, 985 patients per cohort were included in the AIH comparison and 961 per cohort in the PSC comparison. Compared with AIH alone, AIH-PSC had significantly higher hazards of cirrhosis (HR: 3.138), hepatocellular carcinoma (HR: 2.360), liver transplantation (HR: 4.351), and long-term steroid use (HR: 1.690; all P ≤ .012). Compared with PSC alone, AIH-PSC carried higher hazards of cirrhosis (HR: 2.361), liver transplantation (HR: 1.400), and long-term steroid use (HR: 2.283; all P ≤ .048). Hospitalization did not differ in either comparison. AIH-PSC was the strongest independent predictor of CCA vs AIH (adjusted HR: 14.546), yet CCA rates were nearly identical between AIH-PSC and PSC (3.6% vs 3.4%; P = .457), indicating CCA risk is attributable to the PSC component.
Conclusion:
AIH-PSC variant syndrome confers additive liver-related morbidity exceeding either component disease, with significantly higher risks of cirrhosis, hepatobiliary malignancy, liver transplantation, and steroid dependence. CCA risk is driven by the PSC component. These findings support intensified surveillance and early transplant evaluation in this population.
Related Concept Videos
Cirrhosis II: Pathophysiology
Cirrhosis I: Introduction
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Cholecystitis
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Chronic Pancreatitis II: Pathophysiology

